{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:51:00Z","timestamp":1787885460461,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1124\/dmd.124.001675","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T19:15:14Z","timestamp":1710443714000},"page":"432-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP Inhibition"],"prefix":"10.1016","volume":"52","author":[{"given":"Congrong","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-333X","authenticated-orcid":false,"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.124.001675_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","article-title":"Bile Acid sulfation: a pathway of bile acid elimination and detoxification","volume":"108","author":"Alnouti","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.124.001675_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/jpb.1000285","article-title":"Membrane Protein Quantification by Peptide-Based Mass Spectrometry Approaches: Studies on the Organic Anion-Transporting Polypeptide Family","volume":"6","author":"Balogh","year":"2013","journal-title":"J Proteomics Bioinform"},{"key":"10.1124\/dmd.124.001675_bib3","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1200\/JCO.1996.14.11.2923","article-title":"Evaluation of long-term toxicity after chemotherapy for testicular cancer","volume":"14","author":"Bokemeyer","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.124.001675_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.2013.81","article-title":"In vitro methods to support transporter evaluation in drug discovery and development","volume":"94","author":"Brouwer","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001675_bib5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/toxsci\/kfx284","article-title":"Measures of BSEP Inhibition In Vitro Are Not Useful Predictors of DILI","volume":"162","author":"Chan","year":"2018","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.124.001675_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jhep.2015.04.016","article-title":"Drug-induced liver injury: Interactions between drug properties and host factors","volume":"63","author":"Chen","year":"2015","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.124.001675_bib7","doi-asserted-by":"crossref","first-page":"15549","DOI":"10.1021\/acs.jmedchem.1c01256","article-title":"Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases","volume":"64","author":"Cheng","year":"2021","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.124.001675_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.117.242370","article-title":"Bile Salt Homeostasis in Normal and Bsep Gene Knockout Rats with Single and Repeated Doses of Troglitazone","volume":"362","author":"Cheng","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001675_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.livres.2020.05.001","article-title":"Up to date on cholesterol 7 alpha-hydroxylase (CYP7A1) in bile acid synthesis","volume":"4","author":"Chiang","year":"2020","journal-title":"Liver Res"},{"key":"10.1124\/dmd.124.001675_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the intestinal bile acid transporters in bile acid and drug disposition","volume":"201","author":"Dawson","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/dmd.124.001675_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/toxsci\/kfp033","article-title":"Role of hepatic transporters in the disposition and hepatotoxicity of a HER2 tyrosine kinase inhibitor CP-724,714","volume":"108","author":"Feng","year":"2009","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.124.001675_bib12","article-title":"Severe Drug-Induced Liver Injury from Combination Encorafenib\/Binimetinib","volume":"2019","author":"Gravbrot","year":"2019","journal-title":"Case Rep Oncol Med"},{"key":"10.1124\/dmd.124.001675_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/00498250903514607","article-title":"Kinetic analysis of bile acid sulfation by stably expressed human sulfotransferase 2A1 (SULT2A1)","volume":"40","author":"Huang","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.124.001675_bib14","first-page":"443","article-title":"Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma","volume":"71","author":"Keisner","year":"2011","journal-title":"Drugs"},{"key":"10.1124\/dmd.124.001675_bib15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/abbi.2001.2366","article-title":"Short heterodimer partner (SHP) orphan nuclear receptor inhibits the transcriptional activity of aryl hydrocarbon receptor (AHR)\/AHR nuclear translocator (ARNT)","volume":"390","author":"Klinge","year":"2001","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.124.001675_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/17425255.2016.1190831","article-title":"Hepatotoxicity of targeted therapy for cancer","volume":"12","author":"Lee","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.124.001675_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/mp900044x","article-title":"Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes","volume":"6","author":"Li","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001675_bib18","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.21183","article-title":"Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK\/c-jun pathway in human liver cells","volume":"43","author":"Li","year":"2006","journal-title":"Hepatology"},{"key":"10.1124\/dmd.124.001675_bib19","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.124.001675_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1556-0864(15)31506-9","article-title":"The Ras\/Raf\/MAPK pathway","volume":"1","author":"Molina","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1124\/dmd.124.001675_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.124.001675_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/toxsci\/kft176","article-title":"A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development","volume":"136","author":"Morgan","year":"2013","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.124.001675_bib23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.117.247296","article-title":"Establishing Transcriptional Signatures to Differentiate PXR-, CAR-, and AhR-Mediated Regulation of Drug Metabolism and Transport Genes in Cryopreserved Human Hepatocytes","volume":"365","author":"Moscovitz","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.124.001675_bib24","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1200\/JCO.2017.73.5324","article-title":"Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma","volume":"35","author":"Motzer","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.124.001675_bib25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1158\/1078-0432.CCR-06-1539","article-title":"First study of the safety, tolerability, and pharmacokinetics of CP-724,714 in patients with advanced malignant solid HER2-expressing tumors","volume":"13","author":"Munster","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.124.001675_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.620197","article-title":"Transporter Gene Regulation in Sandwich Cultured Human Hepatocytes Through the Activation of Constitutive Androstane Receptor (CAR) or Aryl Hydrocarbon Receptor (AhR)","volume":"11","author":"Niu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.124.001675_bib27","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1124\/dmd.119.088922","article-title":"Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo","volume":"47","author":"Niu","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.124.001675_bib28","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1053\/jhep.2001.24171","article-title":"Characterization of the mouse bile salt export pump overexpressed in the baculovirus system","volume":"33","author":"Noe","year":"2001","journal-title":"Hepatology"},{"key":"10.1124\/dmd.124.001675_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1194\/jlr.M200394-JLR200","article-title":"Appearance of atypical 3 alpha,6 beta,7 beta,12 alpha-tetrahydroxy-5 beta-cholan-24-oic acid in spgp knockout mice","volume":"44","author":"Perwaiz","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.124.001675_bib30","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1021\/acs.molpharmaceut.5b00659","article-title":"Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury","volume":"13","author":"Qiu","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.124.001675_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.121.000828","article-title":"Novel Bile Acid-Dependent Mechanisms of Hepatotoxicity Associated with Tyrosine Kinase Inhibitors","volume":"380","author":"Saran","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"10.1124\/dmd.124.001675_bib32","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s40264-014-0182-7","article-title":"Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges","volume":"37","author":"Senior","year":"2014","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.124.001675_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0005-2760(83)90279-5","article-title":"Vincristine and vinblastine lower plasma cholesterol concentrations in rhesus monkeys","volume":"752","author":"Sethi","year":"1983","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.124.001675_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/17474124.2018.1383154","article-title":"The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury","volume":"12","author":"Thakkar","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1124\/dmd.124.001675_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114270","article-title":"Pharmacological inhibition of MEK1\/2 signaling disrupts bile acid metabolism through loss of Shp and enhanced Cyp7a1 expression","volume":"159","author":"Verzijl","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1124\/dmd.124.001675_bib36","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/cancers15061766","article-title":"Hepatotoxicity of Small Molecule Protein Kinase Inhibitors for Cancer","volume":"15","author":"Vigan\u00f2","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1124\/dmd.124.001675_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hep.23089","article-title":"Compensatory role of P-glycoproteins in knockout mice lacking the bile salt export pump","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/dmd.124.001675_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.124.001675_bib39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1177\/1758834014566428","article-title":"Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma","volume":"7","author":"Welsh","year":"2015","journal-title":"Ther Adv Med Oncol"},{"key":"10.1124\/dmd.124.001675_bib40","article-title":"A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma","volume":"19","author":"Yonezawa","year":"2023","journal-title":"Leuk Res Rep"},{"key":"10.1124\/dmd.124.001675_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115486","article-title":"Oral mometasone furoate administration preserves anti-inflammatory action with fewer metabolic adverse effects in rats","volume":"210","author":"Zimath","year":"2023","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624011644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.124.001675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:16:55Z","timestamp":1739956615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624011644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0090955624011644"],"URL":"https:\/\/doi.org\/10.1124\/dmd.124.001675","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP7A1 Gene Induction via SHP-Dependent or Independent Mechanisms can Increase the Risk of Drug-Induced Liver Injury Independently or in Synergy with BSEP Inhibition","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.124.001675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}